Showing results (21-30 of 176) with videos related to
Sort By:
Pageof 18
Molecular Cancer Therapeutics|January 4, 2018
Rational Approaches for Combination Therapy Strategies Targeting the MAP Kinase Pathway in Solid TumorsAnthony W Tolcher, Wei Peng, Emiliano CalvoThe Oncologist|August 31, 2018
The Current and Evolving Landscape of First-Line Treatments for Advanced Renal Cell CarcinomaEmiliano Calvo, Camillio Porta, Viktor Grünwald, et al.Cancer|June 1, 2026
Integrating antibody-drug conjugates into solid tumor oncology: Current standards and future directionsAndré Mansinho, Joana Albuquerque, Andreia Lopes, et al.The Lancet Regional Health. Europe|May 8, 2026
Antibody-drug conjugates in cancer treatment: from molecular design to clinical implementationAndré Mansinho, Joana Albuquerque, Chiara Barigazzi, et al.American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 2, 2016
Pharmacogenomics, Pharmacokinetics, and Pharmacodynamics in the Era of Targeted TherapiesEmiliano Calvo, Christine Walko, E Claire Dees, et al.Current Opinion in Oncology|July 6, 2017
Immunotherapy-based combinations: current status and perspectivesMaría J de Miguel-Luken, André Mansinho, Valentina Boni, et al.Cancer Treatment Reviews|September 25, 2016
Improvement in survival end points of patients with metastatic renal cell carcinoma through sequential targeted therapyEmiliano Calvo, Manuela Schmidinger, Daniel Y C Heng, et al.Frontiers in Immunology|August 28, 2023
Considerations for the clinical development of immuno-oncology agents in cancerAtanasio Pandiella, Emiliano Calvo, Victor Moreno, et al.CA: a Cancer Journal for Clinicians|November 20, 2013
New approach to cancer therapy based on a molecularly defined cancer classificationJavier Cortés, Emiliano Calvo, Ana Vivancos, et al.Anticancer Research|July 4, 2012
Efficacy of sequential treatment with sunitinib-everolimus in an orthotopic mouse model of renal cell carcinomaJames Larkin, Norbert Esser, Emiliano Calvo, et al.Pageof 18